Clinical Research Center (CRC)
Guatemala City 01010
0 studies enrolling now · 2 studies all time
What they study most
Gout
Studies at this site
Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
— Completed
Extension Study of ABP-671 in Participants With Gout
— Stopped early